- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04690153
Novel Approach of Hayman Uterine Compression Sutures for Management of Severe Atonic Postpartum Hemorrhage: Three Vertical Sutures
Maternal deaths due to uterine atony bleeding are the leading causes of maternal death in our country and all over the world. In this respect, our clinic is among the clinics with the highest number of experience in our country and aims to reduce maternal deaths and mothers who will need intensive care due to bleeding with a hemorrhage stopping technique that will have a serious contribution to both our country and the world literature.
Our primary goal, thanks to the bleeding-stopping technique, to reduce their deaths. Our secondary aim is, thanks to the bleeding-stopping technique we offer, To prevent and reduce the complications seen in mothers during the operative period.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Our research was carried out to our obstetrics clinic between 01 Agustus 2015 - 01 December 2020.
Patients transplanted due to postpartum bleeding and patients requiring surgery due to abnormal postpartum bleeding in our clinic will be included. Patients with a previously known bleeding disorder will not be included in the study. In our study, the parameters of the patients who had bleeding due to postpartum uterine atony and who needed uterine surgery previously underwent triple Hayman compression suture to stop bleeding will be included in the study. Patients with a triple Hayman suture covering the upper 2/3 of the uterus to stop uterine bleeding will be evaluated in the study.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
İ̇stanbul
-
Istanbul, İ̇stanbul, Turkey, 34000
- Pinar Yalcin Bahat
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Postpartum bleeding after birth
- Patients referred to our clinic from an external center due to postpartum bleeding
- Patients who have given birth due to pregnancy older than 24 weeks and have atony bleeding
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduce maternal deaths due to bleeding
Time Frame: 5 years
|
Maternal death due to uterine atony is common all over the world, especially in developing countries.
Thanks to the technique we apply, it is aimed to reduce bleeding and decrease maternal deaths.
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
to prevent and reduce complications seen in mothers in the post-operative period due to bleeding,
Time Frame: 5 years
|
Some complications may occur due to excessive bleeding after uterine atony.
These complications can be permanent or fatal.
(for example, acute renal failure, disseminated intravascular coagulation disorder, etc., it is aimed to reduce these with the applied technique.
|
5 years
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- hayman
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uterine Atony
-
Cynthia WongCompletedUterine Atony With HemorrhageUnited States
-
Kanuni Sultan Suleyman Training and Research HospitalUnknownUterine Atony With Hemorrhage | Ovarian DysfunctionTurkey
-
Stanford UniversityCompletedCesarean Section Complications | Uterine Atony | Uterine Atony With HemorrhageUnited States
-
Maisonneuve-Rosemont HospitalFerring PharmaceuticalsCompletedCesarean Section Complications | Uterine Atony With Hemorrhage | Carbetocin | UterotonicsCanada
-
Necmettin Erbakan UniversityCompletedPostpartum Hemorrhage | Uterine Atony With HemorrhageTurkey
-
Milton S. Hershey Medical CenterWithdrawnBlood Loss Anemia | Uterine Atony With Hemorrhage
-
Stanford UniversityCompletedCesarean Section Complications | Postpartum Hemorrhage | Uterine Atony | Uterine Atony With HemorrhageUnited States
-
Baylor Research InstituteUnknownUterine AtonyUnited States
-
Raydiant Oximetry, Inc.Not yet recruitingCesarean Section Complications | Post Partum Hemorrhage | Uterine Bleeding | Uterine Atony With Hemorrhage